We recently compiled a list of the 12 Best Booming Stocks to Invest in Now.In this article, we are going to take a look at where Option Care Health, Inc. (NASDAQ:OPCH) stands against other best booming stocks to invest in now.
The U.S. stock market closed on a downbeat on Friday, January 31, as investors grappled with the announcement that President Donald Trump’s new tariffs on major trading partners would take effect the following day. The Dow Jones Industrial Average tumbled 0.75%, to close at 44,544.66 and the S&P 500 shed 0.50% to close at 6,040.53, while the Nasdaq Composite slipped 0.28% to 19,627.44. However, the day marked the end of a tumultuous January for traders with the three major averages still managing to post monthly gains. The S&P 500 rose 2.7%, the Nasdaq advanced 1.6%, and the Dow surged 4.7%.
Economic data released on Friday also influenced market sentiment. The December data for the personal consumption expenditures (PCE) price index, which is the preferred inflation gauge of the Federal Reserve, showed an increase of 0.3% from November and a 2.6% annual rate. While this yearly advance was in line with economists’ expectations, it marked an acceleration from the prior month’s annual rate of 2.4% and raised concerns that inflation remains sticky.
Tom Hainlin, a senior investment strategist at U.S. Bank Asset Management Group, noted that the market’s initial reaction to the tariff news was to sell, much like the reaction to the DeepSeek AI developments earlier in the week. Trump will be imposing a 25% tariff on Canada and Mexico, alongside a 10% duty on China. However, Hainlin explained that there are no details about tariffs, whether they are temporary or permanent, or what the potential responses from Canada, Mexico, or China might be.
In an interview with CNBC on January 22, Jamie Dimon, Chairman and CEO at JPMorgan Chase, discussed a range of economic and political issues, including market conditions, the impact of a strong dollar, and the broader economic policies of the United States. Dimon began by addressing that the current state of the U.S. stock market is elevated and stocks trading at a historic price-to-earnings ratio. Dimon believes that the stock prices must be justified by strong growth and there is a need for good outcomes to sustain these levels.
Dimon suggested that the strength of the dollar is an outcome of broader economic factors and that a strong dollar can have its benefits but it can also have negative effects, especially for international companies dealing with tariffs and trade tensions. However, Dimon downplayed the significance of the strong dollar, stating that it is less important than many people think and that the most crucial factor remains economic growth.
Dimon further discussed the challenges of implementing growth strategies, emphasizing that while many recognize the need for change, the real challenge lies in execution. He also addressed the geopolitical issues with Ukraine, Iran, Russia, North Korea, and China, expressing that these issues can affect the world in the long term. He noted that while tariffs are a significant topic of discussion, they are just a tool in a broader economics and national security strategy. Overall, Dimon is cautiously optimistic about the economy and highlighted concerns about government spending, potential inflation, and the global economic landscape.
While the market appears overvalued and faces significant headwinds, some stocks are performing exceptionally well and hold significant potential.
A home infusion nurse in full PPE gown delivering treatments to a patient in their own home.
Our Methodology
To compile our list of the 12 best booming stocks to invest in now, we used Finviz and Yahoo stock screeners to identify the 30 largest companies whose stock prices have increased by at least 35% year-to-date as of January 30. We then used Insider Monkey’s Hedge Fund database to rank 12 stocks according to the largest number of hedge fund holders, as of Q3 2024. The list is sorted in ascending order of hedge fund sentiment.
Why do we care about what hedge funds do? The reason is simple: our research has shown that we can outperform the market by imitating the top stock picks of the best hedge funds. Our quarterly newsletter’s strategy selects 14 small-cap and large-cap stocks every quarter and has returned 275% since May 2014, beating its benchmark by 150 percentage points (see more details here).
Option Care Health, Inc. (NASDAQ:OPCH) is the largest independent provider of home and alternate-site infusion services in the U.S. The company delivers specialty medications and infusion therapy for patients with chronic conditions including infusion therapy, specialty pharmacy, and clinical management.
Option Care Health, Inc.’s (NASDAQ:OPCH) stock has seen a significant increase year to date, driven by its early sales figures for the fourth quarter of 2024 and the full year. The company reported preliminary net revenue of approximately $1.34 billion to $1.35 billion, representing approximately 19.2% to 20.1% growth over the fourth quarter of 2023, against consensus of $1.27 billion. Option Care Health, Inc.’s (NASDAQ:OPCH) full-year 2024 performance was equally impressive, with preliminary net revenue ranging from $4.99 billion to $5.00 billion, reflecting a 16.0% to 16.2% increase over the prior year. Net income for the year was approximately $208.5 million to $212.6 million, or diluted earnings per share of $1.21 to $1.23. These results not only exceeded consensus estimates but also demonstrated the company’s strong operational efficiency and financial discipline.
Option Care Health, Inc.’s (NASDAQ:OPCH) strong financial performance is driven by the company’s core business of providing infusion and home care services, which has seen a consistent and growing demand. The aging population and the increasing prevalence of chronic diseases, such as cancer, have driven the need for specialized home healthcare services. Furthermore, the company’s robust infrastructure, which includes a wide network of skilled healthcare professionals and advanced medical technologies, has played a crucial role in maintaining high service standards and operational efficiency.
Overall OPCH ranks 8th on our list of the best booming stocks to invest in now. While we acknowledge the potential of OPCH as an investment, our conviction lies in the belief that AI stocks hold greater promise for delivering higher returns and doing so within a shorter time frame. If you are looking for an AI stock that is more promising than OPCH but that trades at less than 5 times its earnings, check out our report about the cheapest AI stock.